FDA Flags Medline Kits Over Contaminated BD Applicators
MDLN is trading near its 52-week low of $32.815 (9.9% above the low).
Summary
The FDA has alerted healthcare providers that Medline convenience kits contain recalled BD antiseptic applicators with compromised sterile seals, risking fungal contamination. Medline issued customer letters on June 12 and June 20 instructing quarantine and over-labeling of affected kits. As of August 3, no severe injuries or deaths have been reported. This adds to Medline's recent regulatory challenges, including two FDA warning letters in the past two months. The recall may disrupt surgical kit sales and require costly corrective actions, though the financial impact is not yet quantified.
At the time of this announcement, MDLN was trading at $36.08 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $47.4B. The 52-week trading range was $32.82 to $50.88. This news item was assessed with negative market sentiment and an importance score of 7 out of 10. Source: Benzinga.